JUL 11, 2026 · JOURNAL ARTICLE
Development of a Cre-Inducible Rabl6a Transgenic Mouse Model That Enhances Sarcoma Growth In Vivo
Cancers
This is a mechanistic, preclinical mouse model study demonstrating RABL6A's functional role in sarcoma progression using transgenic mice and CRISPR-induced tumors, without clinical outcome data or translation to human disease.
Study details
DesignPreclinical transgenic mouse model with CRI…
InterventionCre-inducible transgenic Rabl6a expression…
ComparatorDhhCre control mice without transgenic Rabl…